TCG Crossover Management, LLC

Position in TNGX — Tango Therapeutics, Inc.

CIK 1839948 PALO ALTO, CA

Position in TNGX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$283,878,343

+$63,568,338 QoQ

Shares Held

9,081,201

-13.8% QoQ

Ownership

5.39%

of shares outstanding

% of Portfolio

6.82%

of 13F equity value

Holder Rank

of 246 holders

Holding Since

Mar 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TCG Crossover Management, LLC holds $3,891,479,135 across 48 Biotechnology names. TNGX ranks #2 (7.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	6,007,834	$800,603,958
2	TNGX	Tango Therapeutics, Inc. This page	9,081,201	$283,878,343
3	CGON	CG Oncology, Inc.	3,670,206	$260,768,136
4	COGT	Cogent Biosciences, Inc.	4,854,436	$187,866,673
5	IMVT	Immunovant, Inc.	4,457,988	$171,766,277
6	SYRE	Spyre Therapeutics, Inc.	1,900,582	$168,733,669
7	DNTH	Dianthus Therapeutics, Inc. /DE/	1,676,624	$163,437,307
8	MIRM	Mirum Pharmaceuticals, Inc.	1,062,049	$124,334,076

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$283,878,343	9,081,201	-13.8%	Shares	Sole	2026-08-14
2026-03-31	$220,310,005	10,531,071	-17.5%	Shares	Sole	2026-05-15
2025-12-31	$113,072,152	12,762,094	+49.5%	Shares	Sole	2026-02-17
2025-09-30	$71,704,046	8,536,196	-20.5%	Shares	Sole	2025-11-17
2025-06-30	$54,968,320	10,736,000	0.0%	Shares	Sole	2025-08-14
2025-03-31	$14,708,320	10,736,000	0.0%	Shares	Sole	2025-05-14
2024-12-31	$33,174,240	10,736,000	+815.8%	Shares	Sole	2025-02-14
2022-09-30	$4,243,545	1,172,250	0.0%	Shares	Sole	2022-11-14
2022-06-30	$5,310,292	1,172,250	-6.6%	Shares	Sole	2022-08-15
2022-03-31	$9,509,110	1,254,500	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.